Literature DB >> 33522313

Estrogen receptor α: a critical role in successful female cognitive aging.

N E Baumgartner1,2, J M Daniel1,2,3.   

Abstract

Due to potential health risks, current recommendations are that individuals who wish to use hormone therapy to treat menopausal symptoms do so for the shortest period of time possible. In our investigation into how short-term use of estrogens in midlife following loss of ovarian function exerts long-term effects on female cognitive aging in rodents, we discovered a link between the ability of previous exposure to estradiol to enhance memory in the long term and its ability to increase estrogen receptor α (ERα) levels in the hippocampus, a brain area important for memory. Follow-up studies in model systems implicate a role for ERα in enhanced cognitive function independent of ovarian or exogenously administered estrogens. Results are consistent with clinical studies in which brain ERα levels in older women and men are related to cognitive functioning and risk of cognitive decline is associated with polymorphisms in the gene that transcribes ERα. Research in preclinical models reveals mechanisms through which ERα can be activated and affect cognition in the absence of ovarian estrogens, including ligand-independent activation via insulin-like growth factor-1 signaling and activation by brain-derived neuroestrogens. This report reviews preclinical and clinical data that collectively point to the importance of ERα in cognition and highlights the need to differentiate the role of estrogen receptors from their classical ligands as we seek approaches to facilitate successful cognitive aging.

Entities:  

Keywords:  Alzheimer’s disease; Estrogen receptor α; aging; brain; cognition; estrogens; hippocampus; insulin-like growth factor-1; menopause; neuroestrogens

Mesh:

Substances:

Year:  2021        PMID: 33522313      PMCID: PMC8273070          DOI: 10.1080/13697137.2021.1875426

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.024


  58 in total

1.  Timing of cyclic estradiol treatment differentially affects cognition in aged female rhesus monkeys.

Authors:  Mark G Baxter; Anthony C Santistevan; Eliza Bliss-Moreau; John H Morrison
Journal:  Behav Neurosci       Date:  2018-06-28       Impact factor: 1.912

2.  Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.

Authors:  Aileen M Moloney; Rebecca J Griffin; Suzanne Timmons; Rosemary O'Connor; Rivka Ravid; Cora O'Neill
Journal:  Neurobiol Aging       Date:  2010-02       Impact factor: 4.673

Review 3.  Sex and the development of Alzheimer's disease.

Authors:  Christian J Pike
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

4.  Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations.

Authors:  Rosa Maria Corbo; Giuseppe Gambina; Maria Ruggeri; Renato Scacchi
Journal:  Dement Geriatr Cogn Disord       Date:  2006-05-12       Impact factor: 2.959

5.  Transient estradiol exposure during middle age in ovariectomized rats exerts lasting effects on cognitive function and the hippocampus.

Authors:  Shaefali P Rodgers; Johannes Bohacek; Jill M Daniel
Journal:  Endocrinology       Date:  2010-01-12       Impact factor: 4.736

6.  Decreased estrogen receptor-alpha expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients.

Authors:  Xiang-You Hu; Song Qin; Ya-Ping Lu; Rivka Ravid; Dick F Swaab; Jiang-Ning Zhou
Journal:  Acta Neuropathol       Date:  2003-06-19       Impact factor: 17.088

7.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Sally A Shumaker; Claudine Legault; Lewis Kuller; Stephen R Rapp; Leon Thal; Dorothy S Lane; Howard Fillit; Marcia L Stefanick; Susan L Hendrix; Cora E Lewis; Kamal Masaki; Laura H Coker
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

8.  Neuroestrogen-Dependent Transcriptional Activity in the Brains of ERE-Luciferase Reporter Mice following Short- and Long-Term Ovariectomy.

Authors:  Nina E Baumgartner; Elin M Grissom; Kevin J Pollard; Shannon M McQuillen; Jill M Daniel
Journal:  eNeuro       Date:  2019-10-16

9.  From the 90's to now: A brief historical perspective on more than two decades of estrogen neuroprotection.

Authors:  E B Engler-Chiurazzi; M Singh; J W Simpkins
Journal:  Brain Res       Date:  2015-12-29       Impact factor: 3.252

10.  ERα Signaling Is Required for TrkB-Mediated Hippocampal Neuroprotection in Female Neonatal Mice after Hypoxic Ischemic Encephalopathy(1,2,3).

Authors:  Ulas Cikla; Vishal Chanana; Douglas B Kintner; Eshwar Udho; Jens Eickhoff; Wendy Sun; Stephanie Marquez; Lucia Covert; Arel Otles; Robert A Shapiro; Peter Ferrazzano; Raghu Vemuganti; Jon E Levine; Pelin Cengiz
Journal:  eNeuro       Date:  2016-01-28
View more
  2 in total

Review 1.  Sex Differences in Psychostimulant Abuse: Implications for Estrogen Receptors and Histone Deacetylases.

Authors:  Oscar V Torres
Journal:  Genes (Basel)       Date:  2022-05-17       Impact factor: 4.141

Review 2.  Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome.

Authors:  Elizabeth J Andrews; Alessandra C Martini; Elizabeth Head
Journal:  Front Neurosci       Date:  2022-08-12       Impact factor: 5.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.